Literature DB >> 33237012

Musculoskeletal MR Imaging Applications at Ultra-High (7T) Field Strength.

Rajiv G Menon1, Gregory Chang2, Ravinder R Regatte3.   

Abstract

Regulatory approval of ultrahigh field (UHF) MR imaging scanners for clinical use has opened new opportunities for musculoskeletal imaging applications. UHF MR imaging has unique advantages in terms of signal-to-noise ratio, contrast-to-noise ratio, spectral resolution, and multinuclear applications, thus providing unique information not available at lower field strengths. But UHF also comes with a set of technical challenges that are yet to be resolved and may not be suitable for all imaging applications. This review focuses on the latest research in musculoskeletal MR imaging applications at UHF including morphologic imaging, T2, T2∗, and T1ρ mapping, chemical exchange saturation transfer, sodium imaging, and phosphorus spectroscopy imaging applications.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  7 T; Bone; Cartilage; Musculoskeletal MR imaging; Ultrahigh field (UHF) MR imaging

Mesh:

Year:  2020        PMID: 33237012      PMCID: PMC8189542          DOI: 10.1016/j.mric.2020.09.008

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN: 1064-9689            Impact factor:   2.266


  85 in total

Review 1.  Anatomy and variants of the triangular fibrocartilage complex and its MR appearance at 3 and 7T.

Authors:  Iris-M Nöbauer-Huhmann; Michael Pretterklieber; Jochen Erhart; Peter Bär; Pavol Szomolanyi; Claudia Kronnerwetter; Susanna Lang; Klaus M Friedrich; Siegfried Trattnig
Journal:  Semin Musculoskelet Radiol       Date:  2012-05-30       Impact factor: 1.777

Review 2.  MRI of the Musculoskeletal System: Advanced Applications using High and Ultrahigh Field MRI.

Authors:  Hamza Alizai; Gregory Chang; Ravinder R Regatte
Journal:  Semin Musculoskelet Radiol       Date:  2015-11-19       Impact factor: 1.777

3.  Detection of muscle injury in humans with 31-P magnetic resonance spectroscopy.

Authors:  K K McCully; Z Argov; B P Boden; R L Brown; W J Bank; B Chance
Journal:  Muscle Nerve       Date:  1988-03       Impact factor: 3.217

4.  Mitochondrial regulation of phosphocreatine/inorganic phosphate ratios in exercising human muscle: a gated 31P NMR study.

Authors:  B Chance; S Eleff; J S Leigh; D Sokolow; A Sapega
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

Review 5.  An introduction to the pathophysiology of osteoarthritis.

Authors:  A R Poole
Journal:  Front Biosci       Date:  1999-10-15

6.  Dynamic three-dimensional imaging of phosphocreatine recovery kinetics in the human lower leg muscles at 3T and 7T: a preliminary study.

Authors:  Prodromos Parasoglou; Ding Xia; Gregory Chang; Ravinder R Regatte
Journal:  NMR Biomed       Date:  2012-10-13       Impact factor: 4.044

7.  MRI of the knee at 7.0 Tesla.

Authors:  O Kraff; J M Theysohn; S Maderwald; C Saylor; S C Ladd; M E Ladd; J Barkhausen
Journal:  Rofo       Date:  2007-11-14

8.  Cartilage repair of the ankle: first results of T2 mapping at 7.0 T after microfracture and matrix associated autologous cartilage transplantation.

Authors:  S E Domayer; S Apprich; D Stelzeneder; C Hirschfeld; M Sokolowski; C Kronnerwetter; C Chiari; R Windhager; S Trattnig
Journal:  Osteoarthritis Cartilage       Date:  2012-04-26       Impact factor: 6.576

9.  The comparison of the performance of 3 T and 7 T T2 mapping for untreated low-grade cartilage lesions.

Authors:  Vladimir Juras; Markus Schreiner; Didier Laurent; Štefan Zbýň; Vladimir Mlynarik; Pavol Szomolanyi; Benedikt Hager; Celeste Scotti; Jörg Goldhahn; Rahel Heule; Oliver Bieri; Siegfried Trattnig
Journal:  Magn Reson Imaging       Date:  2018-09-19       Impact factor: 2.546

10.  Spatially localized phosphorous metabolism of skeletal muscle in Duchenne muscular dystrophy patients: 24-month follow-up.

Authors:  M T Hooijmans; N Doorenweerd; C Baligand; J J G M Verschuuren; I Ronen; E H Niks; A G Webb; H E Kan
Journal:  PLoS One       Date:  2017-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.